Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02937506 · ClinicalTrials.gov registry record · Phase 4
Patient Satisfaction With Propofol for Out Patient Colonoscopy
A Phase 4 study, sponsored by Mount Carmel Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 600
- Enrollment target
NCT02937506 is a Phase 4 study that has completed, run by Mount Carmel Health System. The registered enrollment target is 600 participants.
The verdict
NCT02937506, a Phase 4 study, has completed, sponsored by Mount Carmel Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 600 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine if patient satisfaction with propofol is better than with non-propofol anesthesia for outpatient colonoscopies.
Interventions
- DRUG Propofol
- DRUG Fentanyl Plus Midazolam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2013-11 |
| Est. Completion | 2016-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02937506
The ClinicalTrials.gov registry entry for NCT02937506 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mount Carmel Health System, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Propofol is the first listed.
NCT02937506 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02937506 about?
NCT02937506 is a clinical study titled "Patient Satisfaction With Propofol for Out Patient Colonoscopy". The primary purpose of this study is to determine if patient satisfaction with propofol is better than with non-propofol anesthesia for outpatient colonoscopies.
What is the current status of trial NCT02937506?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 600 participants. The study started on 2013-11. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02937506?
The interventions under investigation include: Propofol (DRUG), Fentanyl Plus Midazolam (DRUG).
Who is sponsoring clinical trial NCT02937506?
This trial is sponsored by Mount Carmel Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.